(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

3-D MATRIX MEDICAL TECHNOLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

3-D MATRIX MEDICAL TECHNOLOGY

ST13

US500000090515863

Class

5, 44

Filing

90515863

Registration

6854219

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

09/20/2022

Trademark type

Word

Nice classes

5, 44

Filing date

02/06/2021

Registration date

09/20/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/20/2022

Last transaction

09/20/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

First use anywhere

03/01/2020

First use in commerce

06/01/2020

Drawing code

4

Owner type

03

Owner location

Cambridge, MA, JP

Examiner

RHIM, ANDREW

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

3-D Matrix, Ltd.

Representatives

CONSTANTINE LINNIK IP SUPRA, PLLC

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Synthetic peptide hydrogels for medical purposesas an absorbable bulking agenthemostatic agentwound healing agentagent preventing adhesion and scar tissue formationfor tissue protection in generalfor use in surgical proceduresincluding endoscopic surgeriesfor the treatment of disorders and conditions in earnose and throatgastrointestinal tractas an embolic agent in treatment of canceragent for uplifting or separating tissues during surgery; syringes pre-filled with synthetic peptide hydrogel solution for aforementioned uses

Class 44

Providing medical information relating to medical productsabout self-assembling peptide hydrogels and their medical applications via a website

Publications

History of USPTO decisions and trademark events.

27 publications found

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/20/2022

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

09/20/2022

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/17/2022

EXPT

EXPARTE APPEAL TERMINATED

08/10/2022

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

08/10/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/10/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/10/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/09/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/09/2022

ALIE

ASSIGNED TO LIE

08/08/2022

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

07/19/2022

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

07/18/2022

EXPI

EX PARTE APPEAL-INSTITUTED

07/18/2022

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

07/18/2022

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

07/18/2022

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

01/19/2022

GNFR

FINAL REFUSAL E-MAILED

01/19/2022

CNFR

FINAL REFUSAL WRITTEN

01/19/2022

DOCK

ASSIGNED TO EXAMINER

01/03/2022

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

12/28/2021

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

12/28/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/03/2021

GNRT

NON-FINAL ACTION E-MAILED

09/03/2021

CNRT

NON-FINAL ACTION WRITTEN

09/03/2021

DOCK

ASSIGNED TO EXAMINER

08/30/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/11/2021

NWAP

NEW APPLICATION ENTERED

02/10/2021

Continuous trademark protection

Get notified about every new filing that threatens 3-D MATRIX MEDICAL TECHNOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.